Montelukast Prescribing at KENSINGTON PARTNERSHIP
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
1,996
Total Quantity
59.8K
NHS Cost
£3.1K
vs National Avg
+191.5%
KENSINGTON PARTNERSHIP prescribed 1,996 items of Montelukast over the last 12 months at a cost of £3,097 to the NHS. This is 191.5% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
165
Jul 2026
167
Jul 2026
154
Jul 2026
167
Jul 2026
164
Jul 2026
160
Jul 2026
169
Jul 2026
167
Jul 2026
189
Jul 2026
154
Jul 2026
171
Jul 2026
169
Prescribing Details
| Total Items | 1,996 |
|---|---|
| Total Quantity | 59,833 |
| Total NHS Cost | £3,097 |
| Presentations | 5 different forms |
| vs National Average | +191.5% |
Montelukast Prescribing Comparison
| This practice | 1,996 items |
|---|---|
| National average per practice | 685 items |
| Difference | +191.5% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.